Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
about
Virotherapy induces massive infiltration of neutrophils in a subset of tumors defined by a strong endogenous interferon response activity.PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype.Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.Identification of a Novel Compound That Suppresses Breast Cancer Invasiveness by Inhibiting Transforming Growth Factor-β Signaling via Estrogen Receptor α.Breast cancer stem cells and their role in resistance to endocrine therapy.Pro-metastatic tumor-stroma interactions in breast cancer.Overexpression of S-adenosylhomocysteine hydrolase (SAHH) in esophageal squamous cell carcinoma (ESCC) cell lines: effects on apoptosis, migration and adhesion of cells.The exposure of breast cancer cells to fulvestrant and tamoxifen modulates cell migration differently.Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-β signaling pathway.Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization.Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer.Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism.Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.Modification of a Popular Syngeneic Murine Mammary Tumor Model for Immunotherapy Studies
P2860
Q35387710-0BDB5B09-59B4-4668-85BD-0E62C19EA746Q35690099-7D91A84E-FB4D-477D-9B4E-6C21BC343E2DQ36245528-A5242114-12F0-4609-B96D-8D8CD260FFD5Q37013935-EF566136-A05A-49B6-B8DA-67E1F0171A08Q37695500-6741E513-2830-4B71-9A26-05C4E0532ECBQ37901429-61C97128-F1C7-471F-B141-AB55F3651566Q38059502-9E62BBF1-C655-48E4-BDE2-9258A14A6E82Q39034082-A77D023F-9A29-48F8-8AD6-05DCCBB248BBQ39111584-AB81BC00-A075-4184-89D1-3560485862E0Q39544350-B95C9102-7053-4293-9899-00A4E96BF293Q49599218-92DE1724-2809-43BB-8609-D519B077E36EQ49921939-8FA4FCD4-6C11-4C69-8C4D-A0B1E7E1C621Q50055518-F1CFF0D6-475C-4D25-9A23-E7A2CC92BA48Q54610139-6E1CDCA2-97BD-43AE-A902-62E7FC2DA217Q58689099-694E7C64-FFE8-4C9B-878B-F1DD7B4878F0
P2860
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-oestrogens but not oestro ...... -deficient breast cancer cells
@en
Anti-oestrogens but not oestro ...... deficient breast cancer cells.
@nl
type
label
Anti-oestrogens but not oestro ...... -deficient breast cancer cells
@en
Anti-oestrogens but not oestro ...... deficient breast cancer cells.
@nl
prefLabel
Anti-oestrogens but not oestro ...... -deficient breast cancer cells
@en
Anti-oestrogens but not oestro ...... deficient breast cancer cells.
@nl
P2093
P2860
P50
P356
P1476
Anti-oestrogens but not oestro ...... -deficient breast cancer cells
@en
P2093
Annabel C Borley
Chris Smith
Robert I Nicholson
P2860
P2888
P356
10.1186/BCR2206
P577
2008-12-04T00:00:00Z
P5875
P6179
1027731411